Projects per year
Personal profile
Biography
Dean, Faculty of Pharmacy and Pharmaceutical Sciences
Bill Charman is Dean, Faculty of Pharmacy and Pharmaceutical Sciences at Monash University; and the Chair of the FIP (International Pharmaceutical Federation) Education initiative (FIPEd). He received his B Pharm from the Victorian College of Pharmacy (now Monash University) in 1981, his PhD in pharmaceutical chemistry from the University of Kansas in 1985, and a DSc (honoris causa) from the University of London in 2011. He was appointed as the eighth Sir John Monash Distinguished Professor in 2011.
The average annual QS World University rankings for the 2012-2017 period (in the pharmacy and pharmacology discipline) rank Monash University as the number one program in the AsiaPacific, and top ten worldwide (in 2017, Monash pharmacy and pharmacology was ranked number 2 worldwide).
In 2015, in partnership with the Schools of Pharmacy at the University of North Carolina at Chapel Hill (USA) and University College London (UK), Monash formed 'PharmAlliance' to collaboratively undertake major initiatives in education, research and professional engagement.
His research has been characterised by a multidisciplinary and collaborative approach to address major issues in drug discovery (especially for neglected diseases such as malaria), drug delivery and the pharmaceutical sciences. He has published more than 350 scientific papers and communications and given over 170 invited national and international presentations. He has received numerous national and international awards, and in 2016, he was one of seven researchers at MIPS recognised by Thomson Reuters as a HiCi researcher in the field of Pharmacology and Toxicology.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 12 Finished
-
John and Nariel Ware Gift for Fellowship in Pharmacy Education & Leadership
31/10/17 → 30/06/19
Project: Research
-
Low cost, needle-free and non-refrigerated treatment for post-partum haemorrhage
McIntosh, M., Bischof, R., Charman, W., Meeusen, E., Morton, D., Parkington, H. & Prankerd, R.
United States Agency for International Development
30/09/11 → 29/03/13
Project: Research
-
Lymphotropic Prodrugs: A Novel Mechanism for Targeted Drug Delivery
Porter, C., Charman, W. & Stella, V.
Australian Research Council (ARC), Monash University
4/01/11 → 31/12/14
Project: Research
-
Structure-based design of inhibitors of oxidative protein folding in enterobacteriaceae
Scanlon, M., Charman, W., Simpson, J. & Heras, B.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/11 → 31/12/13
Project: Research
-
A Tribute to Professor Per Artursson - Scientist, Explorer, Mentor, Innovator, and Giant in Pharmaceutical Research
Matsson, P., Baranczewski, P., Giacomini, K. M., Andersson, T. B., Palm, J., Palm, K., Charman, W. N. & Bergström, C. A. S., Jan 2021, In: Journal of Pharmaceutical Sciences. 110, 1, p. 2-11 10 p.Research output: Contribution to journal › Editorial › Other › peer-review
Open Access -
Pharmacological Insights Into Safety and Efficacy Determinants for the Development of Adenosine Receptor Biased Agonists in the Treatment of Heart Failure
Rueda, P., Merlin, J., Chimenti, S., Feletou, M., Paysant, J., White, P. J., Christopoulos, A., Sexton, P. M., Summers, R. J., Charman, W. N., May, L. T. & Langmead, C. J., 11 Mar 2021, In: Frontiers in Pharmacology. 12, 15 p., 628060.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Intestinal Lymph Flow, and Lipid and Drug Transport Scale Allometrically From Pre-clinical Species to Humans
Trevaskis, N. L., Lee, G., Escott, A., Phang, K. L., Hong, J., Cao, E., Katneni, K., Charman, S. A., Han, S., Charman, W. N., Phillips, A. R. J., Windsor, J. A. & Porter, C. J. H., 21 May 2020, In: Frontiers in Physiology. 11, 11 p., 458.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile11 Citations (Scopus) -
Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonists
Riddy, D. M., Cook, A. E., Shackleford, D. M., Pierce, T. L., Mocaer, E., Mannoury la Cour, C., Sors, A., Charman, W. N., Summers, R. J., Sexton, P. M., Christopoulos, A. & Langmead, C. J., 1 Jan 2019, In: Neuropharmacology. 144, p. 244-255 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile17 Citations (Scopus) -
Divergent effects of strontium and calcium-sensing receptor positive allosteric modulators (calcimimetics) on human osteoclast activity
Diepenhorst, N. A., Leach, K., Keller, A. N., Rueda, P., Cook, A. E., Pierce, T. L., Nowell, C., Pastoureau, P., Sabatini, M., Summers, R. J., Charman, W. N., Sexton, P. M., Christopoulos, A. & Langmead, C. J., 1 Nov 2018, In: British Journal of Pharmacology. 175, 21, p. 4095-4108 14 p.Research output: Contribution to journal › Article › Research › peer-review
16 Citations (Scopus)
Activities
- 1 Patents
-
Medicines for Malaria Venture (MMV) (External organisation)
Jonathan Vennerstrom (Inventor), Yuxiang Dong (Inventor), Susan Ann Charman (Inventor), Sergio Wittlin (Inventor), Jacques Chollet (Inventor), Darren J. Creek (Inventor), Xiaofang Wang (Inventor), Kamaraj Sriraghavan (Inventor), Lin Zhou (Inventor), Hugues Matile (Inventor) & William N. Charman (Inventor)
29 Nov 2011Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent
Press / Media
-
A$9.8 million fight against superbugs
Jian Li, William Neil Charman, Jiangning Song, Anthony Wayne Purcell, Paul John Hertzog, Darren John Creek, Roger Leigh Nation, Jurgen Bullita & John Dallas Boyce
24/04/14
1 Media contribution
Press/Media: Public Engagement Activities